{"id":21223,"date":"2021-12-08T08:00:24","date_gmt":"2021-12-08T08:00:24","guid":{"rendered":"https:\/\/cannabishealthnews.co.uk\/?p=21223"},"modified":"2021-12-07T16:15:11","modified_gmt":"2021-12-07T16:15:11","slug":"new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients","status":"publish","type":"post","link":"https:\/\/cannabishealthnews.co.uk\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/","title":{"rendered":"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients"},"content":{"rendered":"

Findings from what is thought to be the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0<\/b><\/h3>\n

Preliminary findings from a Phase 1 clinical trial on a new THC-based drug, show evidence of clinical improvements in anxiety, depression, and agitation in Alzheimer\u2019s patients.\u00a0<\/span><\/p>\n

The investigational new drug, IGC-AD1, has been developed by cannabis healthcare company, India Globalization Capital (ICG), and is designed to treat certain symptoms of Alzheimer\u2019s disease.<\/a>\u00a0<\/span><\/p>\n

Alzheimer\u2019s disease impacts around 50 million people worldwide, with the vast majority of these facing debilitating symptoms, including anxiety, depression, and agitation.<\/span><\/p>\n

Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.\u00a0<\/span><\/p>\n

Currently, there is no FDA-approved medication to alleviate symptoms of dementia, such as agitation, due to Alzheimer\u2019s disease.<\/span><\/p>\n

This is the first human clinical trial combining low doses of THC with another molecule to treat symptoms of dementia in Alzheimer\u2019s patients.\u00a0<\/span><\/p>\n

According to IGC, the data collected over the course of the Phase 1 trial, saw evidence of clinical improvements in anxiety, depression, and agitation.\u00a0<\/span><\/p>\n

On the anxiety and depression scales, researchers documented a decrease of approximately 50 per cent to 60 per cent in patients who received the drug.<\/span><\/p>\n

They also documented a decrease in agitation of approximately 35 per cent\u00a0 to 60 per cent in patients who received the drug.\u00a0<\/span><\/p>\n

Based on the preliminary data obtained to date, IGC estimates that the most effective dosage of the drug may be once or twice per day, depending on the symptom.<\/span><\/p>\n

THC, a naturally occurring cannabinoid produced by the cannabis plant, is known for being a psychoactive substance that can impact mental processes in a positive or negative way depending on dosage.\u00a0<\/span><\/p>\n

The IGC trial is based on low or micro-dosing, which is thought to potentially have a promising effect on Alzheimer\u2019s patients.<\/span><\/p>\n

The results of the study have now been submitted to the FDA for approval.<\/span><\/p>\n

Although this data is no guarantee that further studies will produce positive results, the company<\/a> said in a statement: \u201cIGC is encouraged by these initial promising and exciting results, as the potential to improve the quality of life of Alzheimer\u2019s patients and their caregivers could be significant if similar results are repeated in future trials with larger patient pools.\u00a0<\/span><\/p>\n

\u201cWe are in the process of using the results from this Phase 1 study to design and subsequently pursue, based on FDA approval, a placebo-controlled, multi-site trial with a significantly expanded patient population to further test the efficacy of IGC-AD1 on agitation, anxiety, and depression in Alzheimer\u2019s patients.\u201d<\/span><\/p>\n

IGC-AD1 is an investigational new drug that has not been approved as a medication by any regulatory body in any country.\u00a0<\/span><\/p>\n

IGC-AD1\u2019s safety and efficacy will need to be further established through trials on larger and more diverse groups of Alzheimer\u2019s patients.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Findings have been published from what is thought to be the first human trial of a THC-based drug in Alzheimer\u2019s patients<\/p>\n","protected":false},"author":17,"featured_media":21225,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_cbd_carousel_blocks":"[]","content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"footnotes":""},"categories":[134],"tags":[335,877,48,58,56],"yoast_head":"\nNew THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients - Cannabis Health News<\/title>\n<meta name=\"description\" content=\"Findings from the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients\" \/>\n<meta property=\"og:description\" content=\"Findings from the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannabis Health News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-08T08:00:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-07T16:15:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/35.246.32.45\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"729\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sarah Sinclair\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/twitter.com\/sarahlsinclair_\" \/>\n<meta name=\"twitter:site\" content=\"@cannabishnews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sarah Sinclair\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\"},\"author\":{\"name\":\"Sarah Sinclair\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09\"},\"headline\":\"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients\",\"datePublished\":\"2021-12-08T08:00:24+00:00\",\"dateModified\":\"2021-12-07T16:15:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\"},\"wordCount\":490,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/35.246.32.45\/#organization\"},\"image\":{\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg\",\"keywords\":[\"Alzheimer\u2019s disease\",\"dementia\",\"Featured\",\"Medical Cannabis\",\"Research\"],\"articleSection\":[\"Science\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\",\"url\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\",\"name\":\"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients - Cannabis Health News\",\"isPartOf\":{\"@id\":\"https:\/\/35.246.32.45\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg\",\"datePublished\":\"2021-12-08T08:00:24+00:00\",\"dateModified\":\"2021-12-07T16:15:11+00:00\",\"description\":\"Findings from the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage\",\"url\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg\",\"contentUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg\",\"width\":1200,\"height\":729,\"caption\":\"cropped view of senior man playing with puzzles on table\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/35.246.32.45\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Science\",\"item\":\"https:\/\/35.246.32.45\/category\/science\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/35.246.32.45\/#website\",\"url\":\"https:\/\/35.246.32.45\/\",\"name\":\"Cannabis Health News\",\"description\":\"Covering medical cannabis from every angle\",\"publisher\":{\"@id\":\"https:\/\/35.246.32.45\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/35.246.32.45\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/35.246.32.45\/#organization\",\"name\":\"Cannabis Health\",\"url\":\"https:\/\/35.246.32.45\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png\",\"contentUrl\":\"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png\",\"width\":168,\"height\":164,\"caption\":\"Cannabis Health\"},\"image\":{\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks\",\"https:\/\/x.com\/cannabishnews\",\"https:\/\/www.instagram.com\/cannabishealthmagazine\/?hl=en\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09\",\"name\":\"Sarah Sinclair\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/35.246.32.45\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g\",\"caption\":\"Sarah Sinclair\"},\"description\":\"Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK\u2019s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA\u2019s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk \/ Follow us on Twitter: @CannabisHNews \/ Instagram: @cannabishealthmag\",\"sameAs\":[\"https:\/\/cannabishealthnews.co.uk\",\"https:\/\/www.instagram.com\/sarahlsinclair_\/\",\"https:\/\/www.linkedin.com\/in\/sarahlsinclair\/\",\"https:\/\/x.com\/https:\/\/twitter.com\/sarahlsinclair_\"],\"url\":\"https:\/\/cannabishealthnews.co.uk\/author\/sarah_sinclair\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients - Cannabis Health News","description":"Findings from the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/","og_locale":"en_GB","og_type":"article","og_title":"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients","og_description":"Findings from the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0","og_url":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/","og_site_name":"Cannabis Health News","article_publisher":"https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","article_published_time":"2021-12-08T08:00:24+00:00","article_modified_time":"2021-12-07T16:15:11+00:00","og_image":[{"width":1200,"height":729,"url":"https:\/\/35.246.32.45\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg","type":"image\/jpeg"}],"author":"Sarah Sinclair","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/twitter.com\/sarahlsinclair_","twitter_site":"@cannabishnews","twitter_misc":{"Written by":"Sarah Sinclair","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#article","isPartOf":{"@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/"},"author":{"name":"Sarah Sinclair","@id":"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09"},"headline":"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients","datePublished":"2021-12-08T08:00:24+00:00","dateModified":"2021-12-07T16:15:11+00:00","mainEntityOfPage":{"@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/"},"wordCount":490,"commentCount":0,"publisher":{"@id":"https:\/\/35.246.32.45\/#organization"},"image":{"@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg","keywords":["Alzheimer\u2019s disease","dementia","Featured","Medical Cannabis","Research"],"articleSection":["Science"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/","url":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/","name":"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients - Cannabis Health News","isPartOf":{"@id":"https:\/\/35.246.32.45\/#website"},"primaryImageOfPage":{"@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage"},"image":{"@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg","datePublished":"2021-12-08T08:00:24+00:00","dateModified":"2021-12-07T16:15:11+00:00","description":"Findings from the first human trial of a THC-based drug in Alzheimer\u2019s patients, suggest it may alleviate symptoms of dementia.\u00a0","breadcrumb":{"@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#primaryimage","url":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg","contentUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2021\/12\/AdobeStock_241431741.jpeg","width":1200,"height":729,"caption":"cropped view of senior man playing with puzzles on table"},{"@type":"BreadcrumbList","@id":"https:\/\/35.246.32.45\/2021\/12\/08\/new-thc-based-drug-may-reduce-symptoms-of-dementia-in-alzheimers-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/35.246.32.45\/"},{"@type":"ListItem","position":2,"name":"Science","item":"https:\/\/35.246.32.45\/category\/science\/"},{"@type":"ListItem","position":3,"name":"New THC-based drug may reduce symptoms of dementia in Alzheimer\u2019s patients"}]},{"@type":"WebSite","@id":"https:\/\/35.246.32.45\/#website","url":"https:\/\/35.246.32.45\/","name":"Cannabis Health News","description":"Covering medical cannabis from every angle","publisher":{"@id":"https:\/\/35.246.32.45\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/35.246.32.45\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/35.246.32.45\/#organization","name":"Cannabis Health","url":"https:\/\/35.246.32.45\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/","url":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png","contentUrl":"https:\/\/cannabishealthnews.co.uk\/wp-content\/uploads\/2020\/07\/CH-Logo-ICON.png","width":168,"height":164,"caption":"Cannabis Health"},"image":{"@id":"https:\/\/35.246.32.45\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Cannabis-Health-Magazine-1047415772315886\/?ref=bookmarks","https:\/\/x.com\/cannabishnews","https:\/\/www.instagram.com\/cannabishealthmagazine\/?hl=en"]},{"@type":"Person","@id":"https:\/\/35.246.32.45\/#\/schema\/person\/a98debc354a259e7c4d1ddd96afa8a09","name":"Sarah Sinclair","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/35.246.32.45\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6d71f98750925725c2633c3671cd2558?s=96&d=mm&r=g","caption":"Sarah Sinclair"},"description":"Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK\u2019s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA\u2019s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk \/ Follow us on Twitter: @CannabisHNews \/ Instagram: @cannabishealthmag","sameAs":["https:\/\/cannabishealthnews.co.uk","https:\/\/www.instagram.com\/sarahlsinclair_\/","https:\/\/www.linkedin.com\/in\/sarahlsinclair\/","https:\/\/x.com\/https:\/\/twitter.com\/sarahlsinclair_"],"url":"https:\/\/cannabishealthnews.co.uk\/author\/sarah_sinclair\/"}]}},"_links":{"self":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts\/21223"}],"collection":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/comments?post=21223"}],"version-history":[{"count":0,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/posts\/21223\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/media\/21225"}],"wp:attachment":[{"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/media?parent=21223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/categories?post=21223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabishealthnews.co.uk\/wp-json\/wp\/v2\/tags?post=21223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}